Inventor · disambiguated record
Collin Hauskins
Also filed as: HAUSKINS COLLIN · HAUSKINS COLLIN WILLIAM
5 granted patents·8 pending applications·17 citations·filing 2017–2025
71Inventor score
Top patents by PatentIndex Score
13 records- 0191US11066475B2Chimeric antigen receptors specific for B-cell maturation antigen and encoding polynucleotidesJUNO THERAPEUTICS INC·Filed 2018·Granted Jul 20, 2021·10 cites·23 claims
- 0289US11623961B2Antibodies and chimeric antigen receptors specific for B-cell maturation antigenJUNO THERAPEUTICS INC·Filed 2018·Granted Apr 11, 2023·7 cites·35 claims
- 0369US2023365699A1Antibodies and chimeric antigen receptors specific for b-cell maturation antigenJUNO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0461US12428486B2Chimeric antigen receptors specific for B-cell maturation antigen and encoding polynucleotidesJUNO THERAPEUTICS INC·Filed 2021·Granted Sep 30, 2025·0 cites·22 claims
- 0561US2025161359A1Proteinase 3 (pr3) chimeric autoantibody receptor t cells and related methods and usesJUNO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0657US2025059538A1COMPOSITIONS AND METHODS OF tRNA SILENCINGSHAPE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0754US2025242020A1Antibodies and chimeric antigen receptors specific for receptor tyrosine kinase like orphan receptor 1 (ror1)JUNO THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0851US12268741B2Antibodies and chimeric antigen receptors specific for receptor tyrosine kinase like orphan receptor 1 (ROR1)JUNO THERAPEUTICS INC·Filed 2020·Granted Apr 8, 2025·0 cites·49 claims
- 0947US2023028050A1Anti-idiotypic antibodies to bcma-targeted binding domains and related compositions and methodsJUNO THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1044US12304935B2Immunomodulatory polypeptides and related compositions and methodsJUNO THERAPEUTICS INC·Filed 2017·Granted May 20, 2025·0 cites·15 claims
- 1142US2023324408A1Anti-idiotypic antibodies to ror1-targeted binding domains and related compositions and methodsJUNO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1240US2023242654A1Reagents for expanding cells expressing recombinant receptorsJUNO THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1338US2024018268A1Anti-idiotypic antibodies against anti-cd19 antibodiesJUNO THERAPEUTICS INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Collin Hauskins files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →